News - Events

During this webinar, information will be shared about the Heuft Syringer such as its design features, functionality, implementation and benefits. The goal is to ensure that only quality pre-filled syringes reach the market.

This third annual event will look at the insights that can be generated by the use of real-world data to evaluate the effectiveness of pharmaceuticals, and how this data can help industry, payers and healthcare professionals take decisions.  

This event brings together specialists within the pre-filled syringes industry to provide insight into regulation, new digital technology, human studies and systems for device design and delivery.

The pharmaceutical microbiology industry has seen many changes in recent years. These changes include the discovery of new methods for multiplying microbial organisms, enhanced knowledge of the human microbiome, and new regulation. This meeting will bring together experts from industry to discuss data integrity as it affects microbiology methods, environmental monitoring and automated endotoxin testing and process automation.

This conference will explore new discoveries for the treatment of ocular disease, innovations in combination technologies, and the unique challenges companies and healthcare professionals face in treating one of the most complex organs in the human body.

SMi's 13th annual conference on the subject of pre-filled syringes and injectable drug devices will provide insights into future trends in the industry. Topics for discussion will include the European Union's Medical Device Regulation and Article 117, advances in novel drug products and biologics, parenteral packaging for pre-filled syringes, innovations in device design and platforms for combination products.

The aseptic processing industry, or the processing and packaging of a sterile product, has seen many changes. These are due to advances in manufacturing technology and the use of robotics and automation, to name a few aspects. In 2018, the global aseptic processing market was valued at more than $56 trillion. Revenue is expected to increase to around $124 trillion by 2027. The industry continues to adapt to innovative therapies and to demands to deliver treatments to patients faster. This meeting will examine the new technologies and how they will affect the industry.

This two-day conference will bring together representatives of the pharmaceutical and biotechnology industries and academic institutions to provide first-hand information on the latest oligonucleotide clinical candidates. It will also act as a platform for exchanging ideas on one of the biggest challenges facing the industry: how to deliver these new therapies.

This meeting will provide new information on the potential connectivity and software for medical devices and how these devices can be worn during clinical trials. Key regulatory updates and guidance will also be presented by regulatory, notified body and industry experts. The meeting will give a comprehensive outlook for this expanding field.